United Cannabis Corporation’s Award Winning Prana Line Now Available at Santa Ana’s OC3 Dispensary

Dispensary is Part of the CalCann Holding Group

DENVER, CO / ACCESSWIRE / September 14, 2016 / United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United Cannabis”) today announced that its products, including the award-winning Prana Bio Nutrient Medicinals, are now available at the OC3 Dispensary in Santa Ana, California.

Aaron Herzberg, partner at CalCann Holdings – the owner of the OC3 dispensary, commented on the announcement: “We are excited to feature Prana products in our OC3 dispensary. CalCann is committed to helping make cannabis as medicine available to patients across Southern California and feel there is no better product than Prana available to help the seriously ill include cannabis as a part of their treatment regime.”

Mr. Herzberg went on to say, “United Cannabis’ longstanding reputation within the market was especially attractive to us; particularly that they provide access to a nurse dedicated to educating staff and patients with regard to the proper use and dosage of the Prana products. This will be invaluable as we continue our efforts to reach out to healthcare practitioners in Southern California, educating them as to the use of cannabis as medicine.”

Established in 2015, OC3 is a boutique dispensary located at 3122 S Halladay Street in Santa Ana, California. Generally open from 10 am to 8 pm (11 am to 7 pm on Sunday) patients interested in learning more about the products and services offered at the OC3 can call 714-754-1348.

Earnie Blackmon, United Cannabis’ Chief Executive Officer, commented on the announcement, “CalCann Holdings is a great partner for us; Aaron is well-versed in the regulatory, zoning and operational challenges unique to the cannabis industry and continues to build a portfolio of first rate dispensaries throughout California. I am confident that this is just the start of long-term, mutually beneficial relationship.”

About United Cannabis Corporation

The Company’s Prana Bio Medicinal products provide patients a simple, safe, accurate, and easy way to mix match cannabinoids for therapeutic purpose. These products are broken into 5 easy to follow categories that are available in capsules, sublingual’s, and topical delivery methods. The company uses a patent-pending infusion process utilizing select fatty acids, lipids, and specific combination of cannabis derived terpenes to increase bioavailability. Prana Bio Medicinal products are NON-GMO, ethanol free, alcohol free, glycerin free, gluten free, 100% naturally derived, chemical-free, solventless, and hypoallergenic.

For further information, please visit www.unitedcannabis.us.

About CalCann Holdings:

CalCann Holdings, LLC is building a portfolio of cannabis properties in California that are entitled with a municipal license granting eligibility for a state MMRSA (Medical Marijuana Regulation and Safety Act) license. CalCann believes that the steady advancement of cannabis legalization in California, the largest marijuana market in the world, will spur increasingly greater opportunities to acquire properties, attract and retain strong tenants and build value for its investors.

Contact: Staff@UnitedCannabis.us

Phone: 303-386-7321

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

SOURCE: United Cannabis Corporation

ReleaseID: 445255